Plasma B-type natriuretic peptide as a predictor of cardiovascular events in subjects with atrial fibrillation: A community-based study

PLoS ONE

Volumn 8, Issue 12, 2013, Pages

  Nakamura, Motoyuki ^a   Koeda, Yorihiko ^a   Tanaka, Fumitaka ^a   Onoda, Toshiyuki ^a   Itai, Kazuyoshi ^c   Ohsawa, Masaki ^a   Tanno, Kozo ^a   Sakata, Kiyomi ^a   Omama, Shinich ^a   Ishibashi, Yasuhiro ^a   Makita, Shinji ^a   Ohta, Mutsuko ^b   Ogasawara, Kuniaki ^a   Komatsu, Takashi ^a   Okayama, Akira ^c  

^a IWATE MEDICAL UNIVERSITY   (Japan)

^b Iwate Health Service Association   (Japan)

^c FUKUJUJI HOSPITAL   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

BRAIN NATRIURETIC PEPTIDE;

ACUTE CORONARY SYNDROME; ACUTE HEART INFARCTION; AGED; ARTICLE; CARDIOVASCULAR DISEASE; CARDIOVASCULAR RISK; CEREBROVASCULAR ACCIDENT; CHADS2 SCORE; COMMUNITY LIVING; DIAGNOSTIC TEST ACCURACY STUDY; FEMALE; FOLLOW UP; HAZARD RATIO; HEART ATRIUM FIBRILLATION; HEART FAILURE; HUMAN; JAPAN; MAJOR CLINICAL STUDY; MALE; PREDICTIVE VALUE; PROGNOSIS; SENSITIVITY AND SPECIFICITY; SUDDEN CARDIAC DEATH;

AGED; ATRIAL FIBRILLATION; CARDIOVASCULAR DISEASES; FEMALE; HUMANS; MALE; NATRIURETIC PEPTIDE, BRAIN; PROGNOSIS; PROPORTIONAL HAZARDS MODELS; RESIDENCE CHARACTERISTICS; RISK; ROC CURVE;

EID: 84891475341     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0081243     Document Type: Article

References (28)

1. Kannel WB, Benjamin EJ (2009) Current perceptions of the epidemiology of atrial fibrillation. Cardiol Clin 27: 13-24. doi:10.1016/j.ccl.2008.09.015. PubMed: 19111760.
2. Lip GY, Brechin CM, Lane DA (2012) The global burden of atrial fibrillation and stroke: a systematic review of the epidemiology of atrial fibrillation in regions outside North America and Europe. Chest 142: 1489-1498. doi:10.1378/chest.11-2888. PubMed: 22459778.
3. Kannel WB, Abbott RD, Savage DD, McNamara PM (1983) Coronary artery disease and atrial fibrillation. The Framingham Study. Am Heart J 106: 389-396. doi:10.1016/0002-8703(83)90208-9. PubMed: 6869222. (Pubitemid 13028244)
4. Gage BF, Waterman AD, Shannon W, Boechler M, Rich MW et al. (2001) Validation of clinical classification schemes for predicting stroke: results from the National Registry of Atrial Fibrillation. JAMA 285: 2864-2870. doi:10.1001/jama.285.22.2864. PubMed: 11401607. (Pubitemid 32537350)
5. Lip GY, Nieuwlaat R, Pisters R, Lane DA, Crijns HJ (2010) Refining clinical risk stratification for predicting stroke and thromboembolism in atrial fibrillation using a novel risk factor-based approach: the Euro Heart Survey on Atrial Fibrillation. Chest 137: 263-272. doi:10.1378/chest.09-1584. PubMed: 19762550.
6. Kannel WB, Abbott RD, Savage DD, McNamara PM (1982) Epidemiologic features of chronic atrial fibrillation: the Framingham study. N Engl J Med 306: 1018-1022. doi:10.1056/NEJM198204293061703. PubMed: 7062992. (Pubitemid 12155370)
7. Chugh SS, Blackshear JL, Shen WK, Hammill SC, Gersh BJ (2001) Epidemiology and natural history of atrial fibrillation: clinical implications. J Am Coll Cardiol 37: 371-378. doi:10.1016/S0735-1097(00)01107-4. PubMed: 11216949.
8. Wang TJ, Larson MG, Levy D, Benjamin EJ, Leip EP et al. (2004) Plasma natriuretic peptide levels and the risk of cardiovascular events and death. N Engl J Med 350: 655-663. doi:10.1056/NEJMoa031994. PubMed: 14960742. (Pubitemid 38364624)
9. Kistorp C, Raymond I, Pedersen F, Gustafsson F, Faber J et al. (2005) N-terminal pro-brain natriuretic peptide, C-reactive protein, and urinary albumin levels as predictors of mortality and cardiovascular events in older adults. JAMA 293: 1609-1616. doi:10.1001/jama.293.13.1609. PubMed: 15811980. (Pubitemid 40471791)
10. Nakamura M, Tanaka F, Onoda T, Takahashi T, Sakuma M et al. (2010) Gender-specific risk stratification with plasma B-type natriuretic peptide for future onset of congestive heart failure and mortality in the Japanese general population. Int J Cardiol 143: 124-129. doi:10.1016/j.ijcard.2009.01.076. PubMed: 19272660.
11. Silvet H, Young-Xu Y, Walleigh D, Ravid S (2003) Brain natriuretic peptide is elevated in outpatients with atrial fibrillation. Am J Cardiol 92: 1124-1127. doi:10.1016/j.amjcard.2003.07.010. PubMed: 14583372. (Pubitemid 37329544)
12. Li J, Wang L (2006) B-type natriuretic peptide levels in patients with paroxysmal lone atrial fibrillation. Heart Vessels 21: 137-140. doi: 10.1007/s00380-005-0884-y. PubMed: 16715186.
13. Makita S, Nakamura M, Satoh K, Tanaka F, Onoda T et al. (2009) Serum C-reactive protein levels can be used to predict future ischemic stroke and mortality in Japanese men from the general population. Atherosclerosis 204: 234-238. doi:10.1016/j.atherosclerosis.2008.07.040. PubMed: 18790479.
14. Sakuma M, Nakamura M, Tanaka F, Onoda T, Itai K et al. (2010) Plasma B-type natriuretic peptide level and cardiovascular events in chronic kidney disease in a community-based population. Circ J 74: 792-797. doi:10.1253/circj.CJ-09-0834. PubMed: 20160392.
15. Omama S, Yoshida Y, Ogawa A, Onoda T, Okayama A (2006) Differences in circadian variation of cerebral infarction, intracerebral haemorrhage and subarachnoid haemorrhage by situation at onset. J Neurol Neurosurg Psychiatry 77: 1345-1349. doi:10.1136/jnnp.2006.090373. PubMed: 16916854. (Pubitemid 44851993)
16. McKee PA, Castelli WP, McNamara PM, McKee PA, Feinleib M (1971) The natural history of congestive heart failure: the Framingham study. N Engl J Med 285: 1441-1446. doi:10.1056/NEJM197112232852601. PubMed: 5122894.
17. Tunstall-Pedoe H, Kuulasmaa K, Amouyel P, Arveiler D, Rajakangas AM et al. (1994) Myocardial infarction and coronary deaths in the World Health Organization MONICA Project. Registration procedures, event rates, and case-fatality rates in 38 populations from 21 countries in four continents. Circulation 90: 583-612. doi:10.1161/01.CIR.90.1.583. PubMed: 8026046.
18. Pencina MJ, D'Agostino RB Sr, D'Agostino RB Jr, Vasan RS (2008) Evaluating the added predictive ability of a new marker: from area under the ROC curve to reclassification and beyond. Stat Med 27: 157-172. doi:10.1002/sim.2929. PubMed: 17569110. (Pubitemid 351193639)
19. Lee SH, Jung JH, Choi SH, Lee N, Park WJ et al. (2006) Determinants of brain natriuretic peptide levels in patients with lone atrial fibrillation. Circ J 70: 100-104. doi:10.1253/circj.70.100. PubMed: 16377932. (Pubitemid 43021241)
20. Sadanaga T, Mitamura H, Kohsaka S, Ogawa S (2012) Steady-state Btype natriuretic peptide levels in patients with atrial fibrillation of various clinical backgrounds. Heart Vessels 27: 280-286. doi:10.1007/s00380-011-0151-3. PubMed: 21584749.
21. Igarashi Y, Kashimura K, Makiyama Y, Sato T, Ojima K et al. (2001) Left atrial appendage dysfunction in chronic nonvalvular atrial fibrillation is significantly associated with an elevated level of brain natriuretic peptide and a prothrombotic state. Jpn Circ J 65: 788-792. doi:10.1253/jcj.65.788. PubMed: 11548877.
22. Shimizu H, Murakami Y, Inoue S, Ohta Y, Nakamura K et al. (2002) High plasma brain natriuretic polypeptide level as a marker of risk for thromboembolism in patients with nonvalvular atrial fibrillation. Stroke 33: 1005-1010. doi:10.1161/hs0402.105657. PubMed: 11935052. (Pubitemid 34293583)
23. Hijazi Z, Oldgren J, Andersson U, Connolly SJ, Ezekowitz MD et al. (2012) Cardiac biomarkers are associated with an increased risk of stroke and death in patients with atrial fibrillation: a Randomized Evaluation of Long-term Anticoagulation Therapy (RE-LY) substudy. Circulation 125: 1605-1616. doi:10.1161/CIRCULATIONAHA. 111.038729. PubMed: 22374183.
24. Hijazi Z, Wallentin L, Siegbahn A, Andersson U, Christersson C et al. (2013) N-Terminal Pro-B-Type Natriuretic Peptide for Risk Assessment in Patients With Atrial Fibrillation: Insights From the ARISTOTLE Trial (Apixaban for the Prevention of Stroke in Subjects With Atrial Fibrillation). J Am Coll Cardiol 61: 2274-2284. doi:10.1016/j.jacc.2012.11.082. PubMed: 23563134.
25. Troughton RW, Crozier I (2013) Fine tuning risk stratification for atrial fibrillation. J Am Coll Cardiol 61: 2285-2287. doi:10.1016/j.jacc.2013.02.066. PubMed: 23562924.
26. Mukoyama M, Nakao K, Saito Y, Ogawa Y, Hosoda K et al. (1990) Increased human brain natriuretic peptide in congestive heart failure. N Engl J Med 323: 757-758. doi:10.1056/NEJM199009133231114. PubMed: 2143809. (Pubitemid 20288962)
27. Tsutamoto T, Wada A, Maeda K, Hisanaga T, Maeda Y et al. (1997) Attenuation of compensation of endogenous cardiac natriuretic peptide system in chronic heart failure: prognostic role of plasma brain natriuretic peptide concentration in patients with chronic symptomatic left ventricular dysfunction. Circulation 96: 509-516. doi: 10.1161/01.CIR.96.2.509. PubMed: 9244219. (Pubitemid 27329427)
28. Nakamura M, Endo H, Nasu M, Arakawa N, Segawa T et al. (2002) Value of plasma B type natriuretic peptide measurement for heart disease screening in a Japanese population. Heart 87: 131-135. doi: 10.1136/heart.87.2.131. PubMed: 11796549. (Pubitemid 34098373)